GLP Watchdog

Gimme Care vs Hers

Hers has an open FDA warning letter dated September 9, 2025. Gimme Care has none. On compounded semaglutide injection, Gimme Care costs $468 less a year at standing rates: $160 a month against $199 a month at Hers.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Gimme Care / Hers

Gimme Care logo

Gimme Care

8.5/10

Hers logo

Hers

6.8/10

FDA warning letters
None on record
Pharmacy
None named in our record
Lowest standing price
$160/moCompounded semaglutide injection
$199/moCompounded semaglutide injection
States
All 50 states and DC
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked September 2026
Visit Gimme Care
Visit Hers

Neither Gimme Care nor Hers pays us. Links to them earn nothing. Scores: Gimme Care 8.5, Hers 6.8. How we are paid

What the record shows

  1. 01

    Hers has an open FDA warning letter dated September 9, 2025. Gimme Care has none.

  2. 02

    Hers names three pharmacies. Gimme Care names no compounding pharmacy in our record.

  3. 03

    On compounded semaglutide injection, Gimme Care costs $468 less a year at standing rates: $160 a month against $199 a month at Hers.

  4. 04

    Only Gimme Care lists a price for compounded tirzepatide injection. Only Hers lists a price for brand-name tirzepatide pen.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Gimme Care

Hers

Compounded semaglutide injection

$160/moLower

$1,920 a year

$199/mo

$2,388 a year

Compounded tirzepatide injection

$199/mo

$2,388 a year

Not sold or not priced
Brand-name tirzepatide pen
Not sold or not priced

$299/mo

medication only, membership extra; not compared

Price includes
Medication, clinician visits, shipping
Medication
Billed separately
Not stated
Clinician visits, coaching
Cancel any time
Yes, stated
Yes, stated
Minimum term
None on the monthly cycle
None
Refunds
Full refund if canceled before the pharmacy ships; dispensed medication is final sale
No refund guaranteed once the pharmacy has processed an order
Early-exit fee
None stated
Not stated

Read off each seller’s own pages. Gimme Care: October 17, 2026. Hers: September 28, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Gimme Care

8.5/10
  • No FDA warning letter on record
  • $468 a year less on compounded semaglutide injection
  • Sells compounded tirzepatide injection, which Hers does not price
  • Price includes clinician visits
  • Names no compounding pharmacy
Visit Gimme Care

The case for Hers

6.8/10
  • Sells brand-name tirzepatide pen, which Gimme Care does not price
  • Names its compounding pharmacy
  • Open FDA warning letter, September 9, 2025
  • Price leaves out clinician visits and coaching
Visit Hers

Scores

Gimme Care 8.5 · Hers 6.8 out of 10. Six weighted parts.

Value25%

7.2A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

8.5A
vs
B
7.0

Accessibility10%

10.0A
vs
B
10.0

Support10%

7.0A
vs
B
3.0

The score is the same formula for every seller. Payment does not enter it. Method

Gimme Care vs Hers: questions

Hers has an open FDA warning letter dated September 9, 2025. Gimme Care has none. Letters are matched to a seller by company, domain and address, never by a similar name.
Hers names three pharmacies. Gimme Care names no compounding pharmacy in our record.
Gimme Care, by $468 a year at standing rates. Gimme Care: $160 a month, about $1,920 a year. Hers: $199 a month, about $2,388 a year.
Gimme Care states you can cancel at any time; refunds: full refund if canceled before the pharmacy ships; dispensed medication is final sale. Hers states you can cancel at any time; refunds: no refund guaranteed once the pharmacy has processed an order.
Neither Gimme Care nor Hers pays us. Links to them earn nothing. Scores: Gimme Care 8.5, Hers 6.8.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks